In February, researchers from the University of Leicester and the Leicester Diabetes Centre published a review article on obesity in the "International Journal of Obesity," introducing the current and future drug development pipeline for the treatment of obesity, with special attention given to novel therapies based on the mechanisms of gut incretin hormones
GLP-1 and Insulin When GLP-1 medications are used with insulin, their combined glucose-lowering effects can significantly increase the risk of hypoglycemia
Still, many doctors prescribe them off-label to help patients manage their weight because the active ingredient is the same as in Wegovy and Zepbound, just at a different dose
Written By: Ari Yupangco BEAUTY CONTRIBUTOR Ari has been blogging since 2012 about all things beauty with a sprinkle of different topics here and there
Deep lines may begin to appear less prominent, and overall texture improves, giving the face a more lifted and rejuvenated appearance
95% CI, 1.11 to 2.78